Skip to main content
SpringerLink
Log in

Diagnose und Therapie des Zervixkarzinoms

  • Chapter
Gynäkologie upgrade 2002

  • 38 Accesses

Zusammenfassung

Das Zervixkarzinom ist bis heute nach dem Mammakarzinom weltweit nach Inzidenz und Mortalität das zweithäufigste Karzinom der Frau. Bei uns steht es, mitbedingt durch die Vorsorgeuntersuchungen, mit 17/105 invasiven Karzinomen erst an 8. Stelle. Das Carcinoma in situ (Cis) der Zervix wird heute auch in Deutschland etwas häufiger als invasive Karzinome beobachtet. Der Anteil der Stadium-I-Fälle ist von 23% (1950/54) auf 38% (1982/86), regional auf 49% (1990/93) angestiegen [14]; 25% der Erkrankten sind jünger als 43 (37-70) Jahre, der Altersmittelwert beträgt 56,7 Jahre [9].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baltzer J, Ober KG, Zander J (1989) Adjuvant radiotherapy in patients undergoing surgical treatment for carcinoma of the cervix. In: Burghardt E, Monaghan JM (eds) Operative treatment of cervical cancer. Bailliere’s Clin Obstet Gynaecol 2: 999–1011

    Google Scholar 

  2. Benedetti-Panici P, Maneschi F, Scambia G et al. (1996) Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. Gynecol Oncol 62: 19–24

    Article  PubMed  CAS  Google Scholar 

  3. Bolis G, van Zainten-Przybysz I, Scarfone G et al. (1996) Determinants of response to a cisplatin-based regimen as neoadjuvant chemotherapy in stage Ib-llb invasive cervical cancer. Gynecol Oncol 63: 62–65

    Article  PubMed  CAS  Google Scholar 

  4. Bonomi P, Blessing JA, Stehman FB, DiSaia P, Walton L, Major F (1985) Randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix—A Gynecologic Oncology Group study. J Clin Oncol 3: 1079–1085

    PubMed  CAS  Google Scholar 

  5. Burghhardt E, Haas J, Girardi F (1988a) The significance of the parametrium in the operative treatment of cervical cancer. In: Burghardt E, Monaghan JM (eds) Operative treatment of cervical cancer. Bailliere’s Clin Obstet Gynaecol 2: 879–888

    Google Scholar 

  6. DGGG (1998) Diagnostische und therapeutische Standards beim Zervixkarinom. Frauenarzt 39: 1043–1047

    Google Scholar 

  7. Friedberg V (1988) Operative therapy for stage IIb cervical cancer. In: Burghardt E, Monaghan JM (eds) Operative treatment of cervical cancer. Bailliere’s Clin Obstet Gynaecol 2: 973–980

    Google Scholar 

  8. Hacker NF, Wain GV, Nicklin JL (1995) Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 5: 250–256

    Article  PubMed  Google Scholar 

  9. Hölzel D, Klamert A, Schmidt M (1996) Krebs. Haufigkeiten, Befunde und Behandlungsergebnisse. Tumorregister München. Zuckschwerdt, München

    Google Scholar 

  10. Kaser O, Ikle FA, Hirsch HA (1983) Atlas der gynakologischen Operationen. Thieme, Stuttgart

    Google Scholar 

  11. Kreienberg R, Ebert J, Beck Th, Friedberg V (1990) Die Therapie des Zervixkarzinoms in der Univ. Frauenklinik Mainz. ln:Teufel G (Hrsg) Therapie des Zervixkarzinoms. Springer, Berlin Heidelberg New York, S 134–146

    Chapter  Google Scholar 

  12. Meerpohl HG (1999) Praxis der gynakologischen Onkologie. Thieme, Stuttgart

    Google Scholar 

  13. NIH (1997) Consensus statement on cervical cancer. Gynecol Oncol 66: 351–361

    Article  Google Scholar 

  14. Pettersson F (ed) (1994) Annual report on the results of treatment in gynecological cancer, vol 22. Radiumhemmet, Stockholm

    Google Scholar 

  15. Piver MS, Rutledge F, Smith JP (1974) Five classes extended hysterectomy for women with cervical cancer. Obstet Gynecol 44: 265–272

    PubMed  CAS  Google Scholar 

  16. Remy JC, DiMaio Th, Fruchter RG, Sedlis A, Boyce JG, Sohn CK, Rotman M (1990) Adjunctive radiation after radical hysterectomy in stage Ib squamous cell carcinoma of the cervix. Gynecol Oncol 38: 161–165

    Article  PubMed  CAS  Google Scholar 

  17. Sardi J, Giaroli A, Sananes C et al. (1997) Longterm follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results. Gynecol Oncol 67: 61–69

    Article  PubMed  CAS  Google Scholar 

  18. Schmidt-Matthiesen H, Kuhnle H (1991) Präneoplasien und Neoplasien der Cervix Uteri. Klinik der Frauenheilkunde und Geburtshilfe, Bd 11. Urban&Schwarzenberg, Stuttgart, S 142f

    Google Scholar 

  19. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT (1990) Adjuvant radiotherapy following radical hysterectomy for patients with stage Ib and Ma cervical cancer. Gynecol Oncol 37: 390–395

    Article  PubMed  CAS  Google Scholar 

  20. Thomas GM (1993) Editorial. Is neoadjuvant chemotherapy a useful strategy for the treatment of stage Ib cervix carcinoma? Gynecol Oncol 49: 153–155

    Article  PubMed  CAS  Google Scholar 

  21. Winter R, Petru E, Haas J (1988) Pelvic and paraaortic lymphadenectomy in cervical cancer. In: Burghardt E, Monaghan JM (eds) Operative treatment of cervical cancer. Bailliere’s Clin Obstet Gynaecol 2: 857–866

    Google Scholar 

  22. Delgado G, Bundy B, Zaino R et al. (1990) Prospective surgical-pathological study of disease-free interval in patients with stage Ib squamous call carzinoma of the cervix. A GOG study. Gynecol. Oncol. 38: 352–357

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Freiburg, Germany

    A. Pfleiderer

Authors
  1. A. Pfleiderer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Frauenklinik, Moorenstraße 5, 40225, Düsseldorf, Germany

    L. Beck

  2. Schwaigerstraße 33, 92224, Amberg, Germany

    D. Berg

  3. Eichbergstraße 34, 79117, Freiburg, Germany

    A. Pfleiderer

  4. Abteilung Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitäts-Frauenklinik, Voßstraße 2, 69115, Heidelberg, Germany

    T. Strowitzki

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pfleiderer, A. (2002). Diagnose und Therapie des Zervixkarzinoms. In: Beck, L., Berg, D., Pfleiderer, A., Strowitzki, T. (eds) Gynäkologie upgrade 2002. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56142-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56142-9_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-43398-9

  • Online ISBN: 978-3-642-56142-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation